Table 3.
Pain intensity (estimated with visual analogue scale, VAS) and clinical TMD findings in the control group before treatment and after a 6-month follow-up
| Mean | N | standard deviation | Standard error mean | Mean difference | t value | p value | |
|---|---|---|---|---|---|---|---|
| VAS_baseline | 6.720 | 40 | 1.176 | 0.186 | 1.9875 | 13.812 | <0.0001 |
| VAS_followup | 4.733 | 40 | 1.200 | 0.190 | |||
| AMO_baseline (mm) | 44.545 | 40 | 1.846 | 0.292 | −1.0875 | −4.078 | <0.0001 |
| AMO_followup (mm) | 45.633 | 40 | 1.892 | 0.299 | |||
| RL_baseline (mm) | 10.415 | 40 | 0.939 | 0.148 | −0.2975 | −7.218 | <0.0001 |
| RL_followup (mm) | 10.713 | 40 | 0.920 | 0.146 | |||
| LL_baseline (mm) | 10.225 | 40 | 0.932 | 0.147 | −0.2075 | −6.346 | <0.0001 |
| LL_followup (mm) | 10.433 | 40 | 0.847 | 0.134 | |||
| P_baseline (mm) | 9.433 | 40 | 0.677 | 0.107 | −0.4875 | −5.052 | <0.0001 |
| P_followup (mm) | 9.920 | 40 | 0.672 | 0.106 | |||
| PMS_baseline | 9.525 | 40 | 2.987 | 0.472 | 2.150 | 6.569 | <0.0001 |
| PMS_followup | 7.375 | 40 | 3.200 | 0.506 |